IMAC Holdings BioFirma subsidiary earns FDA registered status

Biologics
Alan Condon -

Biofirma, a subsidiary of IMAC Holdings, received "registered" status by the FDA.

Three things to know:

1. The registration allows BioFirma to package, process, store, label and distribute human cells and tissue.

2. IMAC began using BioFirma's NeoCyte regenerative medicine products in its rehabilitation clinics.

3. BioFirma now sells amniotic fluid exosomes to physicians in the U.S. and reported $80,000 from the product's sales during the second quarter of 2019.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.